Capsugel has completed its acquisitions of Xcelience and Powdersize, which are now part of Capsugel’s Dosage Form Solutions business unit.
 
The acquisitions provide Capsugel with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms; development and manufacturing for specialized products such as highly potent and controlled substance compounds; and micronization capabilities that augment the company’s formulation design services and bioavailability enhancement technology platform.